Genetic Technologies
GENE
$2.28
Share price
0.88%
Change (1 day)
132.65%
Change (1 year)
Categories
Genetic Technologies (GENE) - P/B ratio
P/B ratio as of May 2024 : 3.36
According to Genetic Technologies's latest financial reports the company has a price-to-book ratio of 3.36.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Genetic Technologies - P/B ratio (from 2004 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.33 | 38.52% |
| 2022-12-31 | 2.41 | 1.46% |
| 2021-12-31 | 2.37 | -33.09% |
| 2020-12-31 | 3.54 | -54.6% |
| 2019-12-31 | 7.81 | 48.57% |
| 2018-12-31 | 5.25 | 21.85% |
| 2017-12-31 | 4.31 | 235.05% |
| 2016-12-31 | 1.29 | -52.02% |
| 2015-12-31 | 2.68 | -93.62% |
| 2014-12-31 | 42.1 | 857.32% |
| 2013-12-31 | 4.39 | 45.88% |
| 2012-12-31 | 3.01 | -13.71% |
| 2011-12-31 | 3.49 | 163.24% |
| 2010-12-31 | 1.33 | -16.69% |
| 2009-12-31 | 1.59 | 53.47% |
| 2008-12-31 | 1.04 | -54.92% |
| 2007-12-31 | 2.30 | -55.64% |
| 2006-12-31 | 5.18 | 18.3% |
| 2005-12-31 | 4.38 | 7.48% |
| 2004-12-31 | 4.08 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.85 | 44.42% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 2.45 | -27.07% | 🇺🇸 USA |
 Danaher DHR | 3.68 | 9.66% | 🇺🇸 USA |
 LabCorp LH | 2.23 | -33.73% | 🇺🇸 USA |
 Compugen CGEN | 2.93 | -12.83% | 🇮🇱 Israel |
 Neogen NEOG | 0.9322 | -72.25% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.92 | -12.99% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 4.85 | 44.26% | 🇺🇸 USA |